UCB Pharma Among Latest Sponsors Up For CHMP Oral Explanations

17 Oct 2019

A number of companies were due or potentially due to appear before the European Medicines Agency’s drug evaluation committee, the CHMP, this week to answer questions in person about their marketing applications.

Microphone — Companies were due to answer questions from the CHMP this month about their marketing applications • Source: Shutterstock

Sponsors of seven medicines were due or potentially due to appear before the European Medicines Agency this week to provide an oral explanation about marketing authorization applications (MAAs) for which they are seeking pan-EU approval.

Three of these oral explanation meetings concern MAAs for new drugs that are in the later stages of the regulatory review cycle – fostamatinib (Rigel Pharmaceuticals), solriamfetol (Jazz...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Ocaliva: Still No Clarity On Why EU Court Opposed Revocation Of Approval

19 Sep 2024

• By Neena Brizmohun

Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.

Final Chance To Have Your Say: Take Our Reader Survey This Week

16 Sep 2024

• By Nielsen Hobbs

This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

04 Sep 2024

• By Nielsen Hobbs

We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.

Brazil Pilots Digital Drug Pack Inserts

18 Jul 2024

• By Francesca Bruce

A new pilot aims to take Brazil closer to ‘digital transformation.’

US FDA Makary’s Pharma CEO Tour Goes Against Transparency Rhetoric

27 May 2025

• By Sarah Karlin-Smith

FDA Commissioner Martin Makary will give industry a new avenue for access and influence despite his and HHS Secretary Robert F. Kennedy Jr.’s claims that the pharma-FDA relationship is too cozy.

EMA: ‘Sad To See’ Member States Against Patient Engagement Under EU Pharma Reform

27 May 2025

• By Eliza Slawther

The European Medicines Agency’s chief medical officer Steffen Thistrup argued that patients are able to understand the “complex regulatory and scientific issues” that the EMA committees discuss when they assess drugs.